Ipca Labs net profit rises 35 percent to Rs 267.56 crore in Q3
New Delhi: Drug firm Ipca Laboratories on Thursday reported a 35.44 percent rise in consolidated net profit to Rs 267.56 crore for the third quarter ended December 2020, on the back of robust sales in domestic and international markets. The company had posted a net profit of Rs 197.54 crore for the same period of the previous fiscal, Ipca Labs said in a BSE filing.
Its consolidated total income stood at Rs 1,425.21 crore for the quarter under consideration. It was Rs 1,230.99 crore for in the year-ago period, it added.
Indian formulations income was up 8 per cent at Rs 523.16 crore for the quarter ended December this fiscal, and export income rose 21 per cent to Rs 709.25 crore, the company said.
Next Story
